928025-62-1 Usage
General Description
(S)-1-BOC-3-ISOBUTYLPIPERAZINE is a chemical compound with the molecular formula C13H25N3O2. It is a piperazine derivative and a member of the BOC-protected amines family. (S)-1-BOC-3-ISOBUTYLPIPERAZINE is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also utilized as a building block in the production of new chemical entities and drug candidates. BOC-protected amines, like (S)-1-BOC-3-ISOBUTYLPIPERAZINE, are important in organic synthesis due to their stability and their ability to undergo various chemical reactions to produce a wide range of products.
Check Digit Verification of cas no
The CAS Registry Mumber 928025-62-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,8,0,2 and 5 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 928025-62:
(8*9)+(7*2)+(6*8)+(5*0)+(4*2)+(3*5)+(2*6)+(1*2)=171
171 % 10 = 1
So 928025-62-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H26N2O2/c1-10(2)8-11-9-15(7-6-14-11)12(16)17-13(3,4)5/h10-11,14H,6-9H2,1-5H3/t11-/m0/s1
928025-62-1Relevant articles and documents
Expedite protocol for construction of chiral regioselectively N-protected monosubstituted piperazine, 1,4-diazepane, and 1,4-diazocane building blocks
Crestey, Francois,Witt, Matthias,Jaroszewski, Jerzy W.,Franzyk, Henrik
supporting information; experimental part, p. 5652 - 5655 (2009/12/08)
(Chemical Equation Presented) This paper describes the first study of solution-phase synthesis of chiral monosubstituted piperazine building blocks from nosylamide-activated aziridines. The protocol, involving aminolysis of the starting aziridines with ω-amino alcohols and subsequent Fukuyama-Mitsunobu cyclization, offers the advantage of mild conditions as well as short reaction times, and it leads to optically pure N-Boc- or N-Ns-protected piperazines. This four-step sequence, requiring only a single final chromatographic purification, was extended to include novel diazepane and diazocane derivatives.
